REG - Target H'care REIT - Directorate Change

Target Healthcare ReitAnnouncement

26/08/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210826:nRSZ8142Ja&default-theme=true

RNS Number : 8142J  Target Healthcare REIT PLC  26 August 2021

To:                    RNS

Date:                26 August 2021

Company:        Target Healthcare REIT plc

LEI:                   213800RXPY9WULUSBC04

Subject:            Directorate Change

 

 

 

Directorate Change

 

The Board of Directors of Target Healthcare REIT plc is pleased to announce
the appointment of Mr Vince Niblett as an independent non-executive Director
of the Company with effect from 25 August 2021.

 

Mr Niblett has many years of financial and commercial experience having been
the Global Managing Partner Audit for Deloitte.  He previously held a number
of senior leadership roles within Deloitte including as a member of the UK
Board of Partners and of the Global Executive Group and the UK Executive Group
before his retirement from Deloitte in May 2015. During his career at
Deloitte, Mr Niblett served some of the firm's most significant public company
clients, working with them on commercial and strategic issues as well as
providing audit services.

 

Mr Niblett is an independent non-executive director and chairman of the audit
committee of Forterra plc and an independent non-executive director and senior
independent director of Big Yellow Group plc. He is also a trustee of the Ruth
Strauss Foundation.

 

There is no other information required to be disclosed pursuant to paragraph
9.6.13 R of the Listing Rules in relation to this appointment.

 

 

 

All Enquiries:

Kenneth MacKenzie, Gordon Bland

Target Fund Managers Limited

01786 845 912

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABCGDILUDDGBU